AI assistant
Sending…
Arcadia Biosciences, Inc. — Director's Dealing 2015
Sep 11, 2015
35424_dirs_2015-09-11_120a8b70-0db4-49fe-91c8-6d1cb6616236.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Arcadia Biosciences, Inc. (RKDA)
CIK: 0001469443
Period of Report: 2015-09-09
Reporting Person: Reis James Richard (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-09-09 | Common Stock | M | 7500 | $0.44 | Acquired | 20000 | Direct |
| 2015-09-09 | Common Stock | M | 10000 | $1.08 | Acquired | 30000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-09-09 | Employee Stock Option (right to buy) | $0.44 | M | 7500 | Disposed | 2015-12-31 | Common Stock (7500) | Direct |
| 2015-09-09 | Employee Stock Option (right to buy) | $1.08 | M | 10000 | Disposed | 2018-06-30 | Common Stock (10000) | Direct |
Footnotes
F1: The option is fully exercisable as of the date hereof.
More from Arcadia Biosciences, Inc.
Interim / Quarterly Report
2026
May 14
Regulatory Filings
2026
May 14
Regulatory Filings
2026
Apr 3
Board/Management Information
2026
Feb 6
Capital/Financing Update
2026
Jan 28
Capital/Financing Update
2026
Jan 14
M&A Activity
2025
Dec 29
Regulatory Filings
2025
Dec 29
Declaration of Voting Results & Voting Rights Announcements
2025
Dec 23
Annual Report
2025
Nov 19